Interest in long-acting injectable pre-exposure prophylaxis (LAI PrEP) among women in the Women’s Interagency HIV Study (WIHS): A qualitative study across six cities in the United States

Documenti analoghi

• A Qualitative Exploration of Women's Interest in Long-Acting Injectable Antiretroviral Therapy Across Six Cities in the Women's Interagency HIV Study: Intersections with Current and Past Injectable Medication and Substance Use
  di: Philbin, Morgan M., et al.
  Pubblicazione: (2021)
• A multi-site study of women living with HIV’s perceived barriers to, and interest in, long-acting injectable anti-retroviral therapy
  di: Philbin, Morgan M., et al.
  Pubblicazione: (2020)
• Cohort Profile: The Women’s Interagency HIV Study (WIHS)
  di: Adimora, Adaora A, et al.
  Pubblicazione: (2018)
• The Longitudinal Association between Social Support on HIV Medication Adherence and Healthcare Utilization in the Women’s Interagency HIV Study
  di: Chandran, Aruna, et al.
  Pubblicazione: (2019)
• Association Of Hepatitis C With Markers Of Hemostasis In HIV-Infected and Uninfected Women in the Women’s Interagency HIV Study (WIHS)
  di: Kiefer, Elizabeth M., et al.
  Pubblicazione: (2013)